Psychedelic Research Chemicals or RC Chems are new synthetic substances which are structurally similar to the original drug, while being functional analogs. Data on their effects limited due as they’re fairly new and do not have a lot of human consumption history.
Psychedelics are substances (natural or laboratory made) which cause profound changes in a one’s perceptions of reality. While under the influence of hallucinogens, users might hallcuniate visually and auditorily.
This is a commonly used substance with well known effects, but that does not guarantee the substance will be safe. The safety profile has been established based on usage data commonly reported by others.
Disclaimer: Psychedelic drugs offer some of the most powerful and intense psychological experiences. Additionally these substances are illegal in many places. We understand that even though these substances are illegal, their use occurs frequently. We do not condone breaking of the law. By providing accurate information about these substances, we encourage the user to make responsible decisions and practice harm reduction.
5-MeO-MiPT Also known as:
ine, 5-methoxy-N-me[ACD/Index Name] thyl-N-(1-methyleth yl)-
indol-3-yl)ethyl]-N[German][ACD/IUPAC Name] -methyl-2-propanamin
indol-3-yl)ethyl]-N[ACD/IUPAC Name] -methyl-2-propanami ne
indol-3-yl)éthyl]-N[French][ACD/IUPAC Name] -méthyl-2-propanami ne
indol-3-yl)ethyl]-N -methylpropan-2-ami ne
DOL-3-YL)ETHYL](MET HYL)(PROPAN-2-YL)AM INE
ine,5-methoxy-N-met hyl-N-(1-methylethy l)-
YL-?N-?(1-?METHYLET HYL)-?1H-?INDOLE-?3 -?ETHANAMINE
- 5-methoxy MiPT
N-isopropyl tryptam ine
N-(1-methylethyl)-1 H-Indole-3-ethanami ne
N-isopropyl Tryptam ine
- MFCD04972085[MDL number]
- MFCD07437975[MDL number]
indol-3-yl)ethyl)-N -methylpropan-2-ami ne
ndole-3-yl)ethyl-N-[ACD/IUPAC Name] methylpropan-2-amine
l-5-methoxytryptami ne, free base
A potent, stimulating psychedelic tryptamine, sometimes compared to 5-MeO-DiPT. Has an unusually strong body component and weak visual effects. Often said to be very empathogenic.
5-MeO-MiPT is chemically related to tryptamines like 5-MeO-DMT and 5-MeO-DiPT. It produces its psychoactive effects through activity at serotonin receptors in the brain. The synthesis and pharmacology of 5-MeO-MiPT was first reported in 1985 by David Repke and Alexander Shulgin.
Its effects in humans was documented in Shulgin’s book TiHKAL (“Tryptamines I Have Known and Loved”). Anecdotal reports describe 5-MeO-MiPT’s effects as highly stimulating and mildly entactogenic, lacking in typical psychedelic visual distortions. Many users report strong physical and tactile effects that serve to enhance libido and sexual pleasure.
An unpleasant “body load” is also often reported at common to high doses, marked by muscle tension and nausea. Very little is known about the pharmacological properties, metabolism and toxicity of 5-MeO-MiPT, and it has a limited history of human use. It has been sold online as a research chemical.
It is highly advised to use harm reduction practices when using this substance.
Tryptamines share a core structure comprised of a bicylic indole heterocycle attached at R3 to an amino group via an ethyl side chain.
5-MeO-MiPT is substituted at R5 of its indole heterocycle with a methoxy (MeO) functional group CH3O−; it also contains a methyl group and an isopropyl chain bound to the terminal amine RN of its tryptamine backbone (MiPT). 5-MeO-MiPT is the N-substituted isopropyl homologue of 5-MeO-DMT.
|Avg. Mass||246.348 Da|
|Monoisotopic Mass||246.173218 Da|
|5-MeO-MiPT Duration Data|
- Florida: 5-MeO-MiPT is a Schedule I drug in Florida.
- Louisiana: 5-MeO-MiPT is a Schedule I drug (as of June 2013).
- Minnesota: Minnesota banned a series of drugs including 5-MeO-MiPT.
- Repke, D. B., Grotjahn, D. B., & Shulgin, A. T. (1985). Psychotomimetic N-methyl-N-isopropyltryptamines. Effects of variation of aromatic oxygen substituents. Journal of medicinal chemistry, 28(7), 892-896. PMID: 4009612
- The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain (ScienceDirect) | http://www.sciencedirect.com/science/article/pii/S0014299906013811
- Psychotomimetic N-methyl-N-isopropyltryptamines. Effects of variation of aromatic oxygen substituents | http://pubs.acs.org/doi/abs/10.1021/jm00145a007
- The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/17223101
- Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity | http://bja.oxfordjournals.org/content/95/4/434
- Erowid China Psychoactive Law Update: September 2015 | https://www.erowid.org/psychoactives/law/countries/china/china_law_2015_09_27_list_of_newly_controlled_chemicals.pdf
- Finland's Prohibited Psychoactive Substances: December 19, 2014. https://www.erowid.org/psychoactives/law/countries/finland/finland_law1_2014.pdf
- "Verordnung zur Änderung der Anlage des Neue-psychoaktive-Stoffe-Gesetzes und von Anlagen des Betäubungsmittelgesetzes" (PDF) (in German). Bundesanzeiger Verlag. Retrieved December 10, 2019.
- "Anlage NpSG" (in German). Bundesministerium der Justiz und für Verbraucherschutz. Retrieved December 10, 2019.
- "§ 4 NpSG" (in German). Bundesministerium der Justiz und für Verbraucherschutz. Retrieved December 10, 2019.
- Noteikumi par Latvijā kontrolējamajām narkotiskajām vielām, psihotropajām vielām un prekursoriem (Triptamīni) | http://likumi.lv/doc.php?id=121086
- Misuse of Drugs Act 1971 (Legislation.gov.uk) | http://www.legislation.gov.uk/ukpga/1971/38/schedule/2/part/I/paragraph/3
- Misuse of Drugs Act 1971 (Legislation.gov.uk) |http://www.legislation.gov.uk/ukpga/1971/38/schedule/2/part/I#reference-M_F_c7632653-ddad-4420-f307-e3da1e36d30e
- The 2015 Florida Statutes - Title XLVI CRIMES - Chapter 893 - DRUG ABUSE PREVENTION AND CONTROL | http://www.leg.state.fl.us/Statutes/index.cfm?App_mode=Display_Statute&URL=0800-0899/0893/Sections/0893.03.html
- 5-MeO-MiPT Legal Status by Erowid | https://www.erowid.org/chemicals/5meo_mipt/5meo_mipt_law.shtml
- 2015 Minnesota Statutes | https://www.revisor.mn.gov/statutes/?id=152.02
1717 CheMall HE052626
1717 CheMall HE226932
AK Scientific 6735AC
Amadis Chemical A845542
American Custom Chemicals Corp CHM0079957
Ark Pharm, Inc. AK-40608
Aurora Fine Chemicals A30.256.521
Aurora Fine Chemicals K19.150.732
BGS International BG04265087
BGS International BG04265088
Cayman Chemical 11482
Cayman Chemical 11482.0
eNovation Chemicals K58621
EPA DSSTox DTXCID90164605
FDA UNII - NLM L0P1807EUY
Finetech Industry FT-0656387
Laboratory Chemical Safety Summary 2763156
NIST Spectra mainlib_335457
Springer Nature Direct-heating headspace solid-phase microextraction for the screening of illicit drugs
Springer Nature Metabolism and toxicological analyses of hallucinogenic tryptamine analogues being abused in Japan
Springer Nature Simultaneous determination of tryptamine analogues in designer drugs using gas chromatographyu2013mass spectrometry and liquid chromatographyu2013tandem mass spectrometry
Information made possible with:
- PsychonautWiki is a community-driven online encyclopedia that aims to document the field of psychonautics in a comprehensive, scientifically-grounded manner.
- Erowid is a non-profit educational & harm-reduction resource with 60 thousand pages of online information about psychoactive drugs
- PubChem National Center for Bio Informatics
- Chemspider is a free chemical structure database providing fast access to over 34 million structures, properties and associated information.
Additional APIs were used to construct this information. Thanks to ChemSpider, NCBI, PubChem etc.
Data is constantly updated so please check back later to see if there is any more available information on this substance.